Please note, this OEL/ADE monograph also applies to fluoxetine hydrochloride (CAS RN 56296-78-7). Fluoxetine oral therapy is indicated for many different conditions including bulimia nervosa, depressed bipolar disorder, major depressive disorder, obsessive-compulsive disorder, panic disorder and premenstrual dysphoric disorder. Fluoxetine HCl is a psychotropic agent whose anti-depressive, anti-obsessive-compulsive, and anti-bulimic properties are attributed to its inhibition of serotonin uptake in neurons of the central nervous system. Binding to muscarinic, histaminergic, alpha(1)-adrenergic and other receptors in the brain is much less compared to classical tricyclic antidepressants.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Fluoxetine, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.